Adverse Effects

The #FDAStopTheShockDevice petition has received over 2,200 signatures and 800+ comments. A more thorough analysis of those comments is forthcoming, however, we wanted to offer a glimpse of what people shared. The sixth, seventh, and eighth most common words used in the comments submitted through the petition were "damage," "barbaric" and "torture." We must continue the fight to make sure that the FDA hears the people who will be adversely affected by the proposed rule if it becomes an order. There is still a small window of time for you to sign the petition and leave a comment to the FDA.

After long-term use, most people are going to have serious symptoms when stopping SSRIs. Many people are going to have transient, mild to moderate difficulty and some are going to end up falling down the akathisia rabbit hole. That is a long, difficult drop.

An interview with Wendy Dolin who talks about the work of MISSD, the Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin, a non-profit founded to raise awareness of the tragic consequences of drug-induced akathisia.

One thing I noticed, from the moment that I stepped out of my psychiatrist’s office, was how strangely blank and yet clear my mind was. I felt surprisingly calm and relaxed, and I decided to go back for another treatment the next week. What I couldn’t have known then was that after that next “treatment,” life would be completely destroyed for me.

My heart goes out to anyone experiencing withdrawal, but especially those who are so ill they can’t work and are struggling to navigate a heartless and cynical ‘benefits’ system. Their only crime is to have experienced difficulty from a prescribed treatment, yet they are treated as medical pariahs.

Disturbingly, our study and others reveal that the black box warning is now ignored in many countries, since antidepressant prescriptions for children are on the rise again. Despite increasing certainty that antidepressants are ineffective and likely cause suicidal behavior in young people, psychiatry continues to claim that they reduce suicide risk.

The primary factor protecting psychiatry’s unwarranted power and authority is that it is perceived as shielding society from folks who are believed to be dangerous. It would seem, then, that one logical step toward reducing society’s trust in biological psychiatry would be to reveal the evidence of a significant correlation between the use of prescribed psychoactive drugs and the commission of violent acts against oneself or others.

Imagine being a parent at a meeting with educators to discuss Johnny's academics or behavior. Suddenly, your child’s teacher is telling you that he needs to see a doctor for an assessment of a suspected “mental disorder,” which usually leads to a prescription for medication. Warned of “the risks against failing to intervene,” you will likely acquiesce.

When the CDC released data revealing an increasing suicide rate in the US, some experts, speaking to major media outlets, speculated that the increase...

Multiple media sources are reporting on new data from the CDC revealing a substantial increase in the suicide rate in the United States between 1999...

Researchers report that sexual minority adolescents have considered, planned, and attempted suicide substantially more than their heterosexual peers.

A new study suggests that cognitive-behavioral therapy (CBT) may halve the likelihood of re-attempting suicide, for those who have attempted in the past.

The amount of anxiety I felt on these medications — and for a couple of years after — was unfathomable. I felt as though I was trapped in an air-tight vat, constantly gasping for breath. And my thoughts were guided by my state of constant worry and panic.

Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.

Back in 2006, when my son Franklin was in his late twenties and living in a group home in the Boston area, he refused to take Clozaril any more because of the required bi-weekly blood draws. His doctor prescribed Zyprexa as a substitute, and Frank suddenly began to gain weight ... a lot of weight. Later, I would learn that UCLA psychiatrist Dr. William Wirshing had said of Zyprexa prior to its 1996 approval by the FDA: “It is just un-stinkin’-believable. It is the best drug for gaining weight I’ve ever seen.” The doctor indicated that taking ten milligrams of the medication was equivalent to ingesting 1,500 extra calories per day. My outrage knew no bounds.

The larger narratives put forth by psychiatry and neuroscience often eclipse the equally important stories of lived experience. The easiest way to understand how people are engaging spiritually with their prescriptions is to hear it in their own words.

Today a Massachusetts judge sentenced Michelle Carter for the crime of manslaughter in the suicide death of her boyfriend. I was the only psychiatric and medication expert on either side in this trial, and I testified on behalf of Michelle. Other than perhaps her lawyers, I probably know more about the true story than anyone else.

Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...

Many have asked: “Why doesn’t my doctor/provider know what is happening to me?” Benzodiazepine tolerance and withdrawal are not new. So, why isn’t it simple to diagnose and treat? As both a health care provider and a withdrawal sufferer, I’d like to offer an inside and outside perspective on this question.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

School-based strategies such as the “talk to your doctor” campaign about any childhood problem have been extremely effective in helping the pharmaceutical industry to marginalize traditional child-rearing practices and replace them with advice from mental health “experts” and the use of dangerous drugs. These campaigns are reminiscent of now-illegal vintage tobacco ads in which doctors endorsed cigarette smoking.

Psychologist and educator Michael Corrigan was a guest on my radio show and brought up some questions about how to communicate with people about psychiatric drugs. Specifically, he asked, “What are the three most important things for anyone to know about psychiatric drugs?” Here is my answer.

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

A group of researchers recently found serious bias in the reporting of harm due to adverse events in antidepressant medication clinical trials. They report...

Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.